Top compounds associated with response to NYNRIN


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CCLE pan-cancer AAC 0.17 0.0003
mRNA ML210 CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA SKI-II CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA GW-405833 CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0004
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA FK866 GDSC1000 pan-cancer AAC 0.11 0.0006
mRNA masitinib CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC 0.12 0.0006
Download CSV